Current Assets
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)
Moderna Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) decreased by 33.3% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 81.8%, from $11.00M to $2.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
A high or growing balance suggests potential long-term impairment risk and may require closer scrutiny of the investment portfolio's quality.
Detailed definition
This metric tracks the unrealized losses on available-for-sale debt securities that have been in a loss position for twe...
Peer comparison
Used by analysts to evaluate the quality of long-term investment holdings and potential future write-downs.
Metric ID:
afs_debt_securities_unrealized_loss_12m_or_longerHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $21.00M | $176.00M | $223.00M | $289.00M | $289.00M | $254.00M | $147.00M | $114.00M | $85.00M | $33.00M | $22.00M | $11.00M | $7.00M | $5.00M | $3.00M | $2.00M |
| QoQ Change | — | — | — | +738.1% | +26.7% | +29.6% | +0.0% | -12.1% | -42.1% | -22.4% | -25.4% | -61.2% | -33.3% | -50.0% | -36.4% | -28.6% | -40.0% | -33.3% |
| YoY Change | — | — | — | — | — | — | >999% | +44.3% | -34.1% | -60.6% | -70.6% | -87.0% | -85.0% | -90.4% | -91.8% | -84.8% | -86.4% | -81.8% |
Range$0.00 – $289.00M
Avg YoY Growth+45.7%
Median YoY Growth-83.3%
Current Streak11 quarters decline
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) at Other Companies
Frequently Asked Questions
- What is Moderna's available-for-sale debt securities - unrealized loss position (>=12 months)?
- Moderna (MRNA) reported available-for-sale debt securities - unrealized loss position (>=12 months) of $2.00M in Q1 2026.
- How has Moderna's available-for-sale debt securities - unrealized loss position (>=12 months) changed year-over-year?
- Moderna's available-for-sale debt securities - unrealized loss position (>=12 months) decreased by 81.8% year-over-year, from $11.00M to $2.00M.
- What does available-for-sale debt securities - unrealized loss position (>=12 months) mean?
- The value of investments currently worth less than their cost, held for a year or more.